Treatments That Hold Promise for Dermatomyositis

Julie Paik, MD, MHS, discusses JAK inhibitors in dermatomyositis (DM). 00:16 Background 01:01 Remission of Form of DM Treated with Ruxolitinib - Case Study 02:22 Tofacitinib in DM - Case Study 03:46 Tofacitinib in DM - Case Study - Hypothesis 04:25 Tofacitinib in DM - Case Study - Criteria for Study 05:53 Tofacitinib in DM - Case Study - Study Design 06:44 Tofacitinib in DM - Case Study - Results 10:53 Tofacitinib in DM - Case Study - Conclusions